Abstract:Background The neuroinflammatory responses in the spinal cord following bone cancer development have been shown to play an important role in cancer-induced bone pain (CIBP). Lipoxins (LXs), endogenous lipoxygenase-derived eicosanoids, represent a unique class of lipid mediators that possess a wide spectrum of anti-inflammatory and pro-resolving actions. In this study, we investigated the effects of intrathecal injection with lipoxin and related analogues on CIBP in rats. Methods The CIBP model was induced by intra-tibia inoculation of Walker 256 mammary gland carcinoma cells. Mechanical thresholds were determined by measuring the paw withdrawal threshold to probing with a series of calibrated von Frey filaments. Lipoxins and analogues were administered by intrathecal (i.t.) or intravenous (i.v.) injection. The protein level of LXA4 receptor (ALX) was tested by western blot. The localization of lipoxin receptor in spinal cord was assessed by fluorescent immunohistochemistry. Real-time PCR was carried out for detecting the expression of pro-inflammatory cytokines. Results Our results demonstrated that: 1) i.t. injection with the same dose (0.3 nmol) of lipoxin A4 (LXA4), lipoxin B4 (LXB4) or aspirin-triggered-15-epi-lipoxin A4 (ATL) could alleviate the mechanical allodynia in CIBP on day 7 after surgery. ATL showed a longer effect than the others and the effect lasted for 6 hours. ATL administered through i.v. injection could also attenuate the allodynia in cancer rats. 2) The results from western blot indicate that there is no difference in the expression of ALX among the naive, sham or cancer groups. 3) Immunohistochemistry showed that the lipoxin receptor (ALX)-like immunoreactive substance was distributed in the spinal cord, mainly co-localized with astrocytes, rarely co-localized with neurons, and never co-localized with microglia. 4) Real-time PCR analysis revealed that, compared with vehicle, i.t. injection with ATL could significantly attenuate the expression of the mRNA of proinflammatory cytokines (IL-1β and TNF-α) in the spinal cord in CIBP. Conclusions Taken together, the results of our study suggest that LXs and analogues exert strong analgesic effects on CIBP. These analgesic effects in CIBP are associated with suppressing the expression of spinal proinflammatory cytokines.

Down-Regulation of NOX4 Expression in Dorsal Horn of Spinal Cord Could Alleviate Cancer-Induced Bone Pain in Rats by Reducing Oxidative Stress Response.

THE EXPRESSION OF NR1 AND NOS IN THE SPINAL DORSAL HORN IN A BONE CANCER PAIN MODEL IN MICE

Down-Regulation of Toll-Like Receptor 4 Gene Expression by Short Interfering RNA Attenuates Bone Cancer Pain in a Rat Model

Nuclear Factor Kappa B Regulated Monocyte Chemoattractant Protein-1/Chemokine CC Motif Receptor-2 Expressing in Spinal Cord Contributes to the Maintenance of Cancer-Induced Bone Pain in Rats.

Overexpression of Suppressor of Cytokine Signaling 3 in Dorsal Root Ganglion Attenuates Cancer-Induced Pain in Rats

Role of the CXCR4/ALK5/Smad3 Signaling Pathway in Cancer-Induced Bone Pain

Identification of Lncrna and Mrna Expression Profiles in Dorsal Root Ganglion in Rats with Cancer-Induced Bone Pain.

Role of nitric oxide synthase in the development of bone cancer pain and effect of L‑NMMA.

Rosiglitazone Alleviates Mechanical Allodynia of Rats with Bone Cancer Pain through the Activation of PPAR-γ to Inhibit the NF-κB/NLRP3 Inflammatory Axis in Spinal Cord Neurons

Recombinant protein transduction domain-Cu/Zn superoxide dismutase alleviates bone cancer pain via peroxiredoxin 4 modulation and antioxidation

Robust Spinal Neuroinflammation Mediates Mechanical Allodynia in Walker 256 Induced Bone Cancer Rats

Inhibition of Connexin 43 and Phosphorylated NR2B in Spinal Astrocytes Attenuates Bone Cancer Pain in Mice.

Bilateral Downregulation of Nav1.8 in Dorsal Root Ganglia of Rats with Bone Cancer Pain Induced by Inoculation with Walker 256 Breast Tumor Cells

Stage-dependent Anti-Allodynic Effects of Intrathecal Toll-like Receptor 4 Antagonists in a Rat Model of Cancer Induced Bone Pain

Oxytocin ameliorates bone cancer pain by suppressing toll-like receptor 4 and proinflammatory cytokines in rat spinal cord

Inducible Lentivirus-Mediated Sirna Against TLR4 Reduces Nociception in a Rat Model of Bone Cancer Pain

Relief of mechanical allodynia in rat model of bone cancer by intrathecal MCP-1 neutralizing antibody

Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines

Activation of the STING Pathway Induces Peripheral Sensitization Via Neuroinflammation in a Rat Model of Bone Cancer Pain.

Chemokine Receptor CXCR4 Activates the RhoA/ROCK2 Pathway in Spinal Neurons That Induces Bone Cancer Pain

Functional up-regulation of P2X3 receptors in dorsal root ganglion in a rat model of bone cancer pain